Cooley LLP announced today that it represented NextBio, a Santa Clara-based leader in clinical and genomic informatics, in its acquisition by Illumina. Illumina is a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function (more…)

www.cooley.com

|

Davis Polk is advising PricewaterhouseCoopers LLP in connection with PwC’s acquisition of Booz & Company. The transaction is subject to approval by Booz & Company partners, receipt of required regulatory approvals and other customary closing conditions (more…)

www.davispolk.com

|

Davis Polk is advising Ingram Micro Inc. on its acquisition of Shipwire, Inc. The financial terms of the transaction have not been disclosed. The transaction is subject to customary closing conditions, including approval by Shipwire’s stockholders and antitrust clearance (more…)

www.davispolk.com

|

The Firm represented ClubCorp Holdings, Inc. (“ClubCorp”), a portfolio company of KSL Capital Partners, LLC, and a selling stockholder affiliated with KSL Capital Partners, LLC (the “Selling Stockholder”), in connection with an initial public offering of common stock. ClubCorp issued and sold 13,200,000 shares of common stock in the offering and the Selling Stockholder sold 7,499,781 shares of common stock in the offering, including shares that were sold by the Selling Stockholder pursuant to the exercise of the underwriters’ option. The shares of ClubCorp are listed on the New York Stock Exchange under the ticker symbol “MYCC.” (more…)

www.stblaw.com

|

Davis Polk advised Morgan Stanley & Co. LLC and Credit Suisse Securities (USA) LLC as joint book-running managers in connection with the $151.2 million public offering of common stock by Portola Pharmaceuticals, Inc. and certain of its selling stockholders. The common stock is listed on the NASDAQ Global Market under the symbol “PTLA.” (more…)

www.davispolk.com

|

Paul Hastings LLP, a leading global law firm, announced today that it represented BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a pharmaceutical company that develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, in connection with its underwritten offering of $375,000,000 aggregate principal amount of its 0.75% Senior Subordinated Convertible Notes due 2018 and $375,000,000 aggregate principal amount of its 1.50% Senior Subordinated Convertible Notes due 2020 (more…)

www.paulhastings.com

|

O’Melveny & Myers LLP represented Microsemi Corp. in the strategic acquisition of Symmetricom, Inc., a worldwide leader in precision time and frequency technologies. The total transaction value is approximately US$230 million and is subject to customary closing conditions (more…)

www.omm.com

|

Cooley LLP announced today that it advised Depomed, Inc. in its sale of interests in royalty and milestone payments in the Type 2 diabetes therapeutic area to PDL BioPharma, Inc. for $240.5 million. Depomed is a specialty pharmaceutical company that commercializes products for pain and neurology related disorders (more…)

www.cooley.com

|

The Firm represented Sageview Capital LP in connection with its $30 million equity investment in an aggregate $38 million fund-raising by United Capital Financial Partners, Inc., a nationwide registered investment advisory firm. The investment signed and closed on October 14, 2013 (more…)

www.stblaw.com

|

Arent Fox LLP is pleased to announce the continued expansion of its San Francisco office and nationally recognized Intellectual Property and Complex Litigation practices with the addition of patent litigation partner Imran Khaliq. As a key advisor to leading telecom, tech, and medical device companies, Mr. Khaliq represents top brands in patent disputes involving mobile devices, software, biotechnology and medical devices, GPS technologies, semiconductors, and Internet based technologies (more…)

www.arentfox.com

|

Paul Hastings LLP, a leading global law firm, announced today that it represented Infinity World Development Corp., a wholly owned subsidiary of Dubai World, in connection with a successful $1.78 billion refinancing package for CityCenter Holdings, LLC, a 50/50 joint venture of Infinity World and MGM Resorts International (more…)

www.paulhastings.com

|

Troutman Sanders LLP is pleased to announce that Chad Fuller and Victoria Holstein-Childress have joined the firm as partners in the Financial Services Litigation practice. Fuller practices in the firm’s San Diego office, and Holstein-Childress practices in the firm’s Washington, DC office (more…)

www.troutmansanders.com

|